How to buy SomnoMed shares | A$2.09
Own SomnoMed shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder .
SomnoMed Limited is a medical devices business based in Australia. SomnoMed shares (SOM) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $2.09 – a decrease of 12.92% over the previous week. SomnoMed has a trailing 12-month revenue of around $57.3 million.
How to buy shares in SomnoMed
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for SomnoMed . Find the share by name or ticker symbol: SOM. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until SomnoMed reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $2.09, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of SomnoMed . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
How has coronavirus impacted SomnoMed 's share price?
Since the stock market crash in March caused by coronavirus, SomnoMed 's share price has had significant negative movement.
Its last market close was $2.09, which is 38.53% down on its pre-crash value of $3.4 and 109.00% up on the lowest point reached during the March crash when the shares fell as low as $1.
If you had bought $1,000 worth of SomnoMed shares at the start of February 2020, those shares would have been worth $619.20 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $647.06.
SomnoMed share priceUse our graph to track the performance of SOM stocks over time.
SomnoMed shares at a glance
|Latest market close||AUDA$2.09|
|52-week range||AUDA$0.95 - AUDA$3.44|
|50-day moving average||AUDA$2.0218|
|200-day moving average||AUDA$1.4369|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.283|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy SomnoMed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
SomnoMed price performance over time
|1 week (2020-10-13)||-12.92%|
|1 month (2020-09-18)||-0.48%|
|3 months (2020-07-20)||53.68%|
|6 months (2020-04-20)||65.22%|
|1 year (2019-10-18)||-15.73%|
|2 years (2018-10-18)||20.81%|
|3 years (2017-10-20)||-43.18%|
|5 years (2015-10-20)||-14.66%|
Is SomnoMed under- or over-valued?
Valuing SomnoMed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SomnoMed 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SomnoMed 's P/E ratio
SomnoMed 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 130x. In other words, SomnoMed shares trade at around 130x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
SomnoMed 's EBITDA
SomnoMed 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $302,190.
The EBITDA is a measure of a SomnoMed 's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$57.3 million|
|Gross profit TTM||$33.1 million|
|Return on assets TTM||-1.22%|
|Return on equity TTM||-1.7%|
|Market capitalisation||$198.6 million|
TTM: trailing 12 months
SomnoMed share dividends
We're not expecting SomnoMed to pay a dividend over the next 12 months.
Have SomnoMed 's shares ever split?
SomnoMed 's shares were split on a 1:20 basis on 26 November 2009. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SomnoMed shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for SomnoMed shares which in turn could have impacted SomnoMed 's share price.
SomnoMed share price volatility
Over the last 12 months, SomnoMed 's shares have ranged in value from as little as $0.95 up to $3.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while SomnoMed 's is 1.1589. This would suggest that SomnoMed 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.
Frequently asked questions
Ask an Expert